Novo Nordisk's pricing methods from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of price gouging, stating the stark distinction involving U.S. rates and those in Europe and copyright.This led Novo Nordisk to carry out even further research into higher dosages of semaglutide specifically for